introduct
known
infant
viral
respiratori
infect
sever
enough
requir
hospit
admiss
high
risk
develop
recurr
wheez
data
publish
unselect
popul
main
aim
studi
analys
symptomat
asymptomat
respiratori
viral
infect
first
year
life
cohort
infant
recruit
birth
develop
recurr
wheez
patient
method
total
newborn
recruit
nasopharyng
aspir
taken
patient
respiratori
infect
well
visit
vaccin
month
rtnest
pcr
assay
perform
detect
virus
pleas
cite
articl
calvo
c
aguado
ml
ruizchercol
e
e
rm
et
al
infeccion
viral
respiratoria
en
una
cohort
de
durant
el
primer
de
vida
su
papel
en
el
desarrollo
de
sibilancia
pediatr
barc
result
total
sampl
analys
healthi
control
respiratori
infect
sampl
taken
routin
checkup
posit
case
respiratori
infect
posit
p
ci
total
infant
least
posit
respiratori
viral
infect
detect
frequent
viru
rhinoviru
rv
recurr
wheez
found
children
first
year
life
episod
sd
recurr
wheez
present
patient
admit
hospit
first
viral
infect
vs
infant
first
infect
mild
asymptomat
viral
detect
p
ci
conclus
seri
sever
respiratori
infect
lead
hospitalis
first
month
life
risk
factor
develop
wheez
case
mild
rv
infect
de
publish
elsevi
slu
right
reserv
infeccion
respiratoria
infeccion
viral
infeccion
rinoviru
sibilancia
lactant
infeccion
viral
respiratoria
en
una
cohort
de
durant
el
primer
de
vida
su
papel
en
el
desarrollo
de
sibilancia
resumen
la
infeccion
respiratoria
viral
que
requieren
parecen
conferir
riesgo
de
desarrollar
sibilancia
recurrent
pero
existen
poco
dato
publicado
en
poblacion
seleccionada
por
tener
factor
de
riesgo
nuestro
objetivo
princip
fue
analizar
si
la
infeccion
respiratoria
viral
de
diferent
gravedad
durant
el
primer
de
vida
en
una
cohort
de
nacido
suponen
un
mayor
riesgo
de
sibilancia
recurrent
pacient
se
incluyeron
nacido
se
aspirado
lo
cuando
presentaron
una
respiratoria
de
forma
en
lo
control
de
salud
mese
se
estudiaron
viru
respiratorio
mediant
en
cadena
de
polimerasa
pcr
resultado
se
analizaron
muestra
control
de
salud
infeccion
respiratoria
el
de
la
muestra
tomada
en
lo
control
de
salud
fueron
positiva
frent
un
en
la
infeccion
respiratoria
p
ic
un
total
de
lactant
tuvieron
al
meno
una
viral
positiva
durant
el
primer
de
vida
el
viru
frecuentement
identificado
fue
el
rinoviru
rv
en
lactant
se
detectaron
sibilancia
recurrent
durant
su
primer
de
vida
de
episodio
el
de
lo
lactant
cuya
primera
respiratoria
desarrollaron
sibilancia
de
frent
al
de
lo
cuya
primera
fue
leve
acut
respiratori
infect
ari
major
reason
health
care
use
infant
constitut
substanti
econom
burden
although
infect
age
group
frequent
viral
aetiolog
inappropri
antibiot
use
continu
widespread
techniqu
base
polymeras
chain
reaction
pcr
made
aetiolog
diagnosi
ari
possibl
children
made
us
awar
high
preval
asymptomat
viral
infect
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
influenza
viru
flu
clearli
identifi
respiratori
pathogen
recent
studi
analys
role
virus
rhinoviru
rv
human
bocaviru
hbov
although
high
preval
coinfect
respiratori
virus
detect
asymptomat
patient
pose
challeng
interpret
posit
result
known
children
sever
rsv
infect
requir
hospitalis
high
risk
develop
asthma
long
term
even
late
age
year
sigur
et
al
demonstr
also
evid
increas
risk
recurr
wheez
age
year
infant
hospitalis
due
bronchiol
associ
hmpv
fewer
studi
children
admit
hospit
among
would
like
mention
classic
studi
stein
et
al
analys
unselect
cohort
found
milder
infect
rsv
also
increas
risk
develop
wheez
recent
year
role
rv
longterm
predictor
futur
asthma
also
investig
studi
particular
interest
subject
lemansk
et
al
whose
cohort
infant
rv
infect
wheez
first
year
life
increas
risk
develop
wheez
age
year
odd
ratio
studi
assess
risk
develop
asthma
wheez
conduct
select
highrisk
popul
furthermor
littl
known
mild
viral
respiratori
infect
manag
outpati
set
relat
futur
develop
wheez
mention
asymptomat
viral
infect
although
gener
assum
risk
increas
increas
sever
object
prospect
studi
analys
asymptomat
symptomat
infect
vari
sever
cohort
newborn
first
year
life
assess
role
develop
recurr
wheez
secondari
object
analys
aetiolog
clinic
characterist
infect
conduct
prospect
cohort
studi
newborn
analys
associ
past
viral
infect
vari
sever
develop
recurr
wheez
request
particip
newborn
deliv
four
health
care
centr
sur
health
zone
madrid
first
neonat
visit
day
life
parent
guardian
sign
inform
consent
form
complet
questionnair
epidemiolog
data
histori
asthma
atopi
famili
exposur
tobacco
smoke
pregnanc
deliveri
data
number
sibl
nasopharyng
aspir
npa
specimen
collect
visit
routin
checkup
perform
age
month
furthermor
infant
develop
respiratori
symptom
evalu
paediatrician
collect
addit
npa
sampl
consid
children
specimen
collect
routin
wellchild
checkup
healthi
control
even
present
isol
rhinorrhoea
defin
asymptomat
infect
detect
viru
npa
one
patient
defin
clinic
signific
respiratori
infect
case
met
clinic
criteria
respiratori
infect
present
tabl
defin
first
detect
viral
infect
pcr
detect
respiratori
viru
sampl
first
time
life
child
whether
infect
asymptomat
symptomat
manag
outpati
level
symptomat
requir
hospit
admiss
child
met
criteria
respiratori
infect
describ
tabl
paediatrician
conduct
evalu
clinic
data
form
complet
npa
tabl
absenc
respiratori
distress
wheez
defin
bronchiol
first
episod
respiratori
infect
manifest
respiratori
distress
wheez
subsequ
episod
similar
characterist
classifi
recurr
wheez
episod
manifest
inspiratori
dyspnoea
wheez
classifi
laryngotracheobronch
laryng
defin
inspiratori
dyspnoea
without
wheez
defin
pneumonia
evid
focal
infiltr
consolid
chest
radiographi
absenc
wheez
classifi
infect
requir
hospit
admiss
sever
rest
mild
requisit
criteria
met
npa
sampl
collect
kept
c
await
transport
influenza
respiratori
virus
laboratori
centro
nacion
de
nation
centr
microbiolog
hospitalis
patient
npa
sampl
collect
morn
follow
admiss
kept
refriger
transport
three
rtnest
pcr
assay
use
test
respiratori
virus
revers
transcript
rt
first
amplif
reaction
perform
onestep
rtpcr
kit
qiagen
influenza
b
c
detect
previous
describ
pcr
assay
second
multiplex
pcr
assay
use
detect
parainfluenza
viru
piv
coronaviru
enteroviru
rv
presenc
rsva
b
hmpv
hbov
adenoviru
adv
assess
third
rtnest
pcr
assay
use
brq
method
express
discret
data
percentag
continu
data
mean
standard
deviat
compar
clinic
laboratori
characterist
use
student
mann
whitney
u
chisquar
fisher
exact
test
defin
statist
signific
pvalu
less
test
statist
analysi
perform
statist
packag
social
scienc
spss
version
recruit
total
infant
birth
male
born
spanish
parent
latinamerican
ancestri
thirtyf
percent
infant
expos
tobacco
smoke
mother
father
asthma
andor
atopi
patient
born
preterm
gestat
age
week
infant
complet
yearlong
followup
patient
attend
checkup
contact
paediatrician
obtain
inform
clinic
outcom
ultim
includ
analysi
total
sampl
collect
routin
visit
respiratori
infect
suspect
sampl
collect
wellchild
checkup
test
posit
virus
detect
respiratori
infect
case
p
odd
ratio
confid
interv
frequenc
viral
detect
asymptomat
children
healthi
control
increas
proport
age
newborn
age
day
infant
age
month
viru
identifi
frequent
rv
found
case
virus
found
small
proport
case
adv
piv
hbov
hmpv
flu
rsv
fig
infant
includ
studi
least
one
posit
viral
detect
first
year
life
fig
viru
detect
frequent
rv
sampl
follow
piv
adv
rsv
coinfect
detect
case
mean
age
detect
first
viral
infect
month
sd
first
detect
viral
infect
associ
upper
respiratori
tract
infect
patient
bronchiol
remain
sampl
correspond
asymptomat
patient
collect
routin
wellchild
checkup
analys
outcom
infant
least
one
posit
specimen
found
develop
recurr
wheez
first
year
life
mean
sd
episod
rang
fig
rhinoviru
first
viru
detect
patient
asymptomat
time
specimen
collect
routin
checkup
mean
age
infant
develop
recurr
wheez
first
posit
viral
detect
month
sd
three
least
month
old
ten
infant
episod
bronchiol
requir
admiss
frequent
involv
viru
rv
mild
bronchiol
case
manag
outpati
level
sever
case
requir
hospitalis
recurr
wheez
episod
least
one
follow
initi
bronchiol
occur
infant
first
viral
detect
correspond
sever
infect
requir
admiss
compar
infant
whose
first
detect
correspond
mild
infect
manag
outpati
level
asymptomat
infect
p
odd
ratio
ci
total
infant
receiv
montelukast
budesonid
followup
admit
hospit
manag
outpati
level
first
posit
viral
detect
differ
famili
histori
asthma
atopi
children
without
recurr
wheez
episod
infect
manag
outpati
set
correspond
infant
total
sampl
episod
mean
sd
frequent
symptom
fever
case
rhinorrhoea
cough
respiratori
distress
nonspecif
symptom
frequent
diagnos
upper
respiratori
tract
infect
bronchiol
lesser
incid
recurr
wheez
laryng
pneumonia
patient
infiltr
radiolog
examin
requir
hospit
admiss
followup
virus
detect
infect
rv
case
follow
piv
rsv
hmpv
flu
fig
caus
agent
upper
respiratori
tract
infect
rv
case
follow
piv
adv
came
bronchiol
rv
detect
rsv
hmpv
case
analys
total
hospit
admiss
correspond
infant
cohort
infant
posit
viral
detect
five
patient
admit
twice
first
year
life
fiftyeight
percent
admit
patient
femal
mean
age
admiss
month
sd
month
rang
day
month
fortytwo
percent
present
fever
mean
c
sd
c
last
day
sd
sixtyeight
percent
episod
requir
oxygen
supplement
mean
day
sd
twentysix
percent
infiltr
detect
radiolog
diagnos
bronchiol
case
wheez
episod
upper
respiratori
tract
infect
pneumonia
infant
receiv
antibiot
respiratori
syncyti
viru
detect
case
rv
viral
coinfect
detect
case
consider
number
infant
test
posit
least
one
respiratori
viru
first
year
life
observ
percentag
cohort
half
cohort
experienc
least
one
symptomat
infect
treat
outpati
level
mean
symptomat
infect
year
rang
approxim
requir
hospit
admiss
rhinoviru
viru
detect
frequent
symptomat
well
asymptomat
infant
eleven
percent
infant
posit
virolog
result
went
develop
recurr
wheez
first
year
life
risk
much
higher
patient
requir
admiss
due
bronchiol
odd
ratio
compar
patient
whose
first
infect
mild
asymptomat
data
consist
find
studi
conduct
rhedin
et
al
analys
group
paediatr
outpati
respiratori
infect
group
asymptomat
control
rhedin
et
al
detect
respiratori
virus
case
n
control
n
p
rhinoviru
viru
identifi
frequent
case
control
respect
although
infect
rv
common
recent
studi
use
nucleotid
sequenc
demonstr
prolong
presenc
rhinoviru
rna
respiratori
tract
follow
upper
respiratori
tract
infect
rare
healthi
infant
infant
detect
rv
rna
repeat
sampl
least
day
apart
like
correspond
new
infect
anoth
studi
found
detect
viru
strain
week
apart
unusu
studi
found
rv
detect
signific
proport
infant
classifi
healthi
routin
vaccin
visit
probabl
take
isol
rhinorrhoea
account
frequent
symptom
children
contraind
vaccin
howev
possibl
rhinorrhoea
actual
present
symptom
mild
rv
infect
unfortun
data
percentag
infant
consid
healthi
control
rhinorrhoea
sole
symptom
consist
hypothesi
jartti
et
al
accord
rv
alway
caus
actual
infect
may
may
clinic
relev
although
author
like
jansen
et
al
found
higher
rv
load
children
acut
symptomat
infect
compar
asymptomat
children
utokaparch
et
al
detect
significantli
higher
rv
load
infect
lower
respiratori
tract
other
like
takeyama
et
al
found
correl
viral
load
diseas
sever
rv
infect
rate
clinic
signific
viral
load
respiratori
sampl
well
establish
measur
viral
load
patient
also
ought
highlight
small
percentag
coinfect
found
cohort
case
seri
includ
previou
studi
research
group
found
percentag
coinfect
hospitalis
children
rhinoviru
infect
believ
age
patient
substanti
proport
specimen
collect
infant
age
less
month
decis
includ
mild
asymptomat
infect
posit
virolog
may
account
low
proport
coinfect
cohort
studi
newborn
design
similar
van
der
gugten
et
al
found
rv
infect
manifest
wheez
first
year
life
risk
factor
develop
recurr
wheez
futur
although
assess
sever
acut
episod
mild
infect
without
wheez
associ
increas
risk
recurr
wheez
author
reach
conclus
reach
base
cohort
infect
rv
rsv
suffici
sever
caus
bronchiol
requir
hospit
admiss
risk
factor
develop
wheez
earli
first
year
life
followup
cohort
immedi
futur
allow
us
learn
whether
risk
wheez
continu
higher
earli
childhood
lemansk
et
al
suggest
sever
infect
risk
factor
develop
asthma
recurr
wheez
variou
studi
demonstr
sever
bronchiol
associ
rv
infect
increas
risk
asthma
comment
studi
conduct
select
popul
case
seri
analys
symptomat
asymptomat
infect
sever
earli
age
less
month
first
episod
unselect
popul
contribut
broader
pictur
subject
although
studi
strength
unselect
sampl
test
respiratori
virus
oppos
preval
presenc
asymptomat
infect
ought
comment
certain
methodolog
aspect
collect
weekli
sampl
studi
viral
shed
durat
also
perform
genotyp
rv
durat
followup
short
number
patient
recurr
wheez
small
nevertheless
believ
associ
found
studi
worth
consid
abl
reach
broader
conclus
upcom
year
state
respiratori
infect
first
month
life
sever
enough
requir
hospitalis
risk
factor
develop
recurr
wheez
studi
partial
fund
